Mechanistically, spironolactone counteracted the aldosterone-induced rise in monocyte adhesion in coronary arteries of the pigs by decreasing the expression of TRPC1 and TRPC6 channels in coronary arteries, reducing MetS-associated atherosclerosis, endothelial dysfunction and vasoconstriction [86]. The gene discussed is TRPC6; the disease is metabolic syndrome.